Skip to main content

Francisco Javier Carvajal Rodriguez

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca
Francisco Javier Carvajal Rodriguez

Francisco Javier Carvajal Rodriguez

Francisco Javier Carvajal Rodriguez

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

WomEC, desenvolupament d'una eina molecular per la millora del diagnòstic en càncer d'endometri.

IP: Eva Colas Ortega
Collaborators: Antonio Gil Moreno, Miriam Izquierdo Sans, Francisco Javier Carvajal Rodriguez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 33960
Reference: AGAUR/DI2022_1/GIL
Duration: 01/08/2022 - 31/07/2025

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

Related professionals

Jaime Llata Ortega

Jaime Llata Ortega

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Hanaa Boudoukhan Benriyyan

Hanaa Boudoukhan Benriyyan

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Ana Torcida Alonso

Ana Torcida Alonso

Research technician
Stroke research
Read more
Lluria Cornellas Escayola

Lluria Cornellas Escayola

Main researcher
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.